| Date Filed | Type | Description |
| 03/08/2023 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Adaptive Biotechnologies Corp|
Txns:
| Granted 14,775 shares
@ $0
Granted 23,329 options to buy
@ $8.46, valued at
$197.4k
|
|
| 03/01/2023 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 10,416 shares
@ $61.12, valued at
$636.6k
Exercised 13,180 restricted stock units
@ $0
Exercised 9,312 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 4,764 shares
@ $62.72, valued at
$298.8k
Exercised 10,374 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 4,527 shares
@ $64.55, valued at
$292.2k
Exercised 9,705 rights
@ $0 |
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,994 shares
@ $0
Granted 41,006 options to buy
@ $0.56, valued at
$23k
|
|
| 04/01/2022 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 13,043 shares
@ $1.15, valued at
$15k
|
|
| 03/18/2022 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Exercised 229,757 options to buy
@ $5.7, valued at
$1.3M
Exercised 4,612 options to buy
@ $21.68, valued at
$100k
Exercised 2,253 options to buy
@ $44.37, valued at
$100k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 52,722 restricted stock units
@ $0 |
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Exercised 31,133 shares
@ $78.33, valued at
$2.4M
Sold 14,409 shares
@ $79.55, valued at
$1.1M
Exercised 94,425 options to buy
@ $9.07, valued at
$856.4k
Exercised 96,758 options to buy
@ $10.82, valued at
$1M
Exercised 31,133 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Granted 6,407 shares
@ $0 |
|
| 01/04/2022 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 6,000 shares
@ $2.5, valued at
$15k
|
|
| 11/03/2021 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 16,922 shares
@ $93.88, valued at
$1.6M
|
|
| 10/05/2021 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 17,078 shares
@ $93.64, valued at
$1.6M
|
|
| 10/01/2021 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 2,930 shares
@ $5.12, valued at
$15k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 19,970 shares
@ $107.5, valued at
$2.1M
|
|
| 07/06/2021 |
4
| Conroy Kevin T (President and CEO) has filed a Form 4 on EXACT SCIENCES CORP|
Txns:
| Sold 7,784 shares
@ $123.43, valued at
$960.8k
|
|
| 07/01/2021 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 1,805 shares
@ $8.31, valued at
$15k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 1,723 shares
@ $8.71, valued at
$15k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|